HealthEquity Competitors

Trip.com Group (NASDAQ:TCOM) and HealthEquity (NASDAQ:HQY) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Valuation & Earnings

This table compares Trip.com Group and HealthEquity's revenue, earnings per share (EPS) and valuation.

Trip.com Group has higher revenue and earnings than HealthEquity. Trip.com Group is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Trip.com Group and HealthEquity's net margins, return on equity and return on assets.

Volatility & Risk

Trip.com Group has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Trip.com Group and HealthEquity, as reported by MarketBeat.com.

Trip.com Group presently has a consensus price target of $36.5571, indicating a potential downside of 7.22%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Trip.com Group.

Insider and Institutional Ownership

98.0% of HealthEquity shares are held by institutional investors. 23.0% of Trip.com Group shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

HealthEquity beats Trip.com Group on 11 of the 15 factors compared between the two stocks.

FLEETCOR Technologies (NYSE:FLT) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares FLEETCOR Technologies and HealthEquity's revenue, earnings per share and valuation.

FLEETCOR Technologies has higher revenue and earnings than HealthEquity. FLEETCOR Technologies is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares FLEETCOR Technologies and HealthEquity's net margins, return on equity and return on assets.

Risk and Volatility

FLEETCOR Technologies has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for FLEETCOR Technologies and HealthEquity, as provided by MarketBeat.

FLEETCOR Technologies presently has a consensus price target of $284.6667, indicating a potential upside of 2.53%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given FLEETCOR Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe FLEETCOR Technologies is more favorable than HealthEquity.

Insider & Institutional Ownership

94.3% of FLEETCOR Technologies shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 5.7% of FLEETCOR Technologies shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

FLEETCOR Technologies beats HealthEquity on 10 of the 15 factors compared between the two stocks.

Farfetch (NYSE:FTCH) and HealthEquity (NASDAQ:HQY) are both retail/wholesale companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Farfetch and HealthEquity's revenue, earnings per share and valuation.

HealthEquity has lower revenue, but higher earnings than Farfetch. Farfetch is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Farfetch and HealthEquity's net margins, return on equity and return on assets.

Risk and Volatility

Farfetch has a beta of 3.53, indicating that its stock price is 253% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Farfetch and HealthEquity, as provided by MarketBeat.

Farfetch presently has a consensus price target of $55.0769, indicating a potential downside of 0.13%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given Farfetch's stronger consensus rating and higher possible upside, equities analysts clearly believe Farfetch is more favorable than HealthEquity.

Insider & Institutional Ownership

65.7% of Farfetch shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

HealthEquity beats Farfetch on 9 of the 15 factors compared between the two stocks.

Lyft (NASDAQ:LYFT) and HealthEquity (NASDAQ:HQY) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Lyft and HealthEquity's revenue, earnings per share and valuation.

HealthEquity has lower revenue, but higher earnings than Lyft. Lyft is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Lyft and HealthEquity's net margins, return on equity and return on assets.

Risk and Volatility

Lyft has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Lyft and HealthEquity, as provided by MarketBeat.

Lyft presently has a consensus price target of $59.6563, indicating a potential downside of 3.83%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than Lyft.

Insider & Institutional Ownership

71.3% of Lyft shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 22.9% of Lyft shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

HealthEquity beats Lyft on 11 of the 15 factors compared between the two stocks.

Broadridge Financial Solutions (NYSE:BR) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Broadridge Financial Solutions and HealthEquity's revenue, earnings per share and valuation.

Broadridge Financial Solutions has higher revenue and earnings than HealthEquity. Broadridge Financial Solutions is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Broadridge Financial Solutions has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Insider & Institutional Ownership

85.0% of Broadridge Financial Solutions shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 2.0% of Broadridge Financial Solutions shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Broadridge Financial Solutions and HealthEquity's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent recommendations and price targets for Broadridge Financial Solutions and HealthEquity, as provided by MarketBeat.

Broadridge Financial Solutions presently has a consensus price target of $154.1667, indicating a potential upside of 10.95%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given Broadridge Financial Solutions' higher possible upside, equities analysts clearly believe Broadridge Financial Solutions is more favorable than HealthEquity.

Summary

HealthEquity beats Broadridge Financial Solutions on 8 of the 15 factors compared between the two stocks.

Akamai Technologies (NASDAQ:AKAM) and HealthEquity (NASDAQ:HQY) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Akamai Technologies and HealthEquity's top-line revenue, earnings per share and valuation.

Akamai Technologies has higher revenue and earnings than HealthEquity. Akamai Technologies is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Akamai Technologies has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Insider and Institutional Ownership

89.1% of Akamai Technologies shares are owned by institutional investors. Comparatively, 98.0% of HealthEquity shares are owned by institutional investors. 2.4% of Akamai Technologies shares are owned by insiders. Comparatively, 3.7% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Akamai Technologies and HealthEquity's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for Akamai Technologies and HealthEquity, as provided by MarketBeat.

Akamai Technologies currently has a consensus price target of $120.3889, indicating a potential upside of 28.62%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given Akamai Technologies' higher possible upside, research analysts clearly believe Akamai Technologies is more favorable than HealthEquity.

Summary

Akamai Technologies beats HealthEquity on 8 of the 15 factors compared between the two stocks.